Dr. Joseph D. Rosen

Horst Klueppelberg is a Hematologist Oncology specialist and an Oncologist in Gilbert, Arizona. Dr. Klueppelberg is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Marginal Zone Lymphoma (MZL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Chronic B-Cell Leukemia (CBCL). Dr. Klueppelberg is currently accepting new patients.

Dr. Kalmadi joined Ironwood Cancer and Research Centers in 2008 and serves as Chief Medical Officer.  After finishing his medical schooling in India, Dr. Sujith Kalmadi completed his residency training and fellowship at the Cleveland Clinic in Cleveland, Ohio. He then served as academic clinical faculty at the Cleveland Clinic School of Medicine (Lerner School) in Cleveland, Ohio and subsequently at Baylor College of Medicine in Houston, Texas. During his tenure at these prestigious institutions, he pioneered several novel clinical research trials which have been lauded at national scientific meetings and published in peer reviewed journals. His areas of clinical and research interests include several solid tumors and hematological disorders. He currently resides in Chandler with his wife and three children, and enjoys tennis, chess and racquetball during his spare time. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Kalmadi is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Lung Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Severe Congenital Neutropenia.

Allison Rosenthal is a Hematologist Oncology specialist and a Hematologist in Phoenix, Arizona. Dr. Rosenthal has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.